Dishman Carbogen Amcis Board of Directors

Get the latest insights into the leadership at Dishman Carbogen Amcis. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Janmejay R Vyas Chairman
Mr. Arpit J Vyas Global Managing Director
Mrs. Deohooti J Vyas Whole Time Director
Mr. Rajendra S Shah Independent Director
Mr. Subir Kumar Das Independent Director
Mr. Maitri K Mehta Independent Director

Dishman Carbogen Amcis Share price

DCAL

263.3

4.25 (-1.59%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:59 IST
BUYSELL
Today's High

271.95

Today's Low

261.05

52 Week Low

161.21

52 Week High

307.98

The current prices are delayed, login to your account for live prices

Dishman Carbogen Amcis FAQs

The board at Dishman Carbogen Amcis consists of experienced professionals, including Mr. Janmejay R Vyas , Mr. Arpit J Vyas , and others, overseeing the company’s strategic and corporate governance.

Directors at Dishman Carbogen Amcis are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Janmejay R Vyas is the current chairman at Dishman Carbogen Amcis.

Executive directors at Dishman Carbogen Amcis are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Dishman Carbogen Amcis adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Dishman Carbogen Amcis, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.